R.J. Reynolds Tobacco Co. (RJR) has filed a Modified Risk Tobacco Product Application to the FDA for several varieties of its Camel Snus product. The Tobacco Control Act requires FDA authorization before any manufacturer can make statements that claim that its product is less harmful or presents a lower risk of disease than other tobacco products. The Act also requires that the FDA make the application materials available and accept comments on them. To view RJR’s application, visit the FDA’s website. The Tobacco Products Scientific Advisory Committee (TPSAC) will evaluate the application at the committee’s meeting on September 13-14, 2018. Members of the public health community can submit comments on the merits of this application. You can submit your comment on Regulations.gov. Comments are due by June 18, 2017. The FDA has not yet scheduled a meeting of the Tobacco Products Scientific Advisory Committee to comment on the application.
Camel Snus MRTP Application